Advancing Intestinal Organoid Technology Toward Regenerative Medicine

Tetsuya Nakamura, Toshiro Sato

研究成果: Review article

31 引用 (Scopus)

抜粋

With the emergence of technologies to culture intestinal epithelial cells in vitro as various forms of intestinal organoids, there is growing interest in using such cultured intestinal cells as a source for tissue engineering and regenerative medicine. One such approach would be to combine the organoid technology with methodologies to engineer the culture environment, particularly the three-dimensional scaffold materials, to generate intestines that exquisitely recapitulate their original structures and functions. Another approach to use organoids for regenerative medicine would be to urge them to mature into functional intestines by implanting them into hosts. This process includes the tissue-engineered small intestine that uses synthetic scaffolds for tissue regeneration and direct organoid transplantation that takes advantage of submucosal tissues in the native intestines as a scaffold. Further study in these subfields could lead to the development of therapeutic options to use different types of organoids with various cell types in regenerative medicine for intestinal diseases in humans.

元の言語English
ページ(範囲)51-60
ページ数10
ジャーナルCMGH
5
発行部数1
DOI
出版物ステータスPublished - 2018 1 1

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

フィンガープリント Advancing Intestinal Organoid Technology Toward Regenerative Medicine' の研究トピックを掘り下げます。これらはともに一意のフィンガープリントを構成します。

  • これを引用